Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
about
sameAs
Pioglitazone for adults with high risk of developing type 2 diabetes mellitusPioglitazone for people with impaired glucose tolerance or impaired fasting blood glucosePioglitazone for people with impaired glucose tolerance or impaired fasting blood glucoseTreatment of prediabetesInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesType 2 diabetes in East Asians: similarities and differences with populations in Europe and the United StatesType 2 diabetes can be prevented with early pharmacological interventionUpdate on pre-diabetes: Focus on diagnostic criteria and cardiovascular riskXylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db MiceArsenic exposure is associated with diminished insulin sensitivity in non-diabetic Amish adultsRole of prediabetes in stroke.Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study.Actos Now for the prevention of diabetes (ACT NOW) study.Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice.Plasma glucose concentration and prediction of future risk of type 2 diabetes.Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht Study.Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects.Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetesRelationships of pancreatic beta-cell function with microalbuminuria and glomerular filtration rate in middle-aged and elderly population without type 2 diabetes mellitus: a Chinese community-based analysisCould pre-diabetes be considered a clinical condition? opinions from an endocrinologist and a cardiologist.One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study.Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart StudyThe relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose toleranceThe longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI.Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndromeThe role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Chronic variable stress improves glucose tolerance in rats with sucrose-induced prediabetes.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adultsReal-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study.DNA methylation of microRNA-375 in impaired glucose toleranceComprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practiceDo static and dynamic insulin resistance indices perform similarly in predicting pre-diabetes and type 2 diabetes?Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: a comparative study.
P2860
Q24187448-09F1C3F5-B992-46F4-9A9B-117EAC0E10C9Q24195168-D2D1B567-3ACD-464B-9BA0-7E6300F7B68FQ24202245-AA6B508F-D39B-49FB-8B53-4DEF17EBBD00Q26783350-BE749E30-958B-4528-AE93-E3FC6CF668E5Q26783350-F2AFF22D-E504-4953-87DB-7FD871AA7ABAQ26830871-6F89405C-2BA7-4BCF-B69A-6EDCA74BE883Q26830871-93901936-7ED9-4671-B517-CA2FEF7B6EEBQ26859746-1B8E4CAB-D68A-4820-9251-832592533883Q26859746-E034C38B-E309-4ABB-8600-46F7BD6BE4BAQ27694430-49C16112-2B9B-4054-B126-77F9611FFF8BQ27694430-FB98CD04-1059-4ED9-A8C1-7205592515FFQ28073749-571EF48E-695D-4785-A9DA-F58E725F28DBQ28073749-C0948786-317A-42D2-8A16-A175C487C9F0Q28354289-454D3457-E423-412B-96B8-FEAC09D77CC6Q28354289-FD163F64-6771-4760-8720-565D5CB7A944Q28387333-805D0265-F7EE-47CD-99C6-F3BB639A896AQ28387333-CDC75DB9-A9C6-4D72-BF15-0F661B220031Q30235932-1BE7516A-7737-4998-AEBA-8ABB713497C4Q30235932-8914741B-0BD3-4DF3-A04B-C137BEE6B441Q30382436-B7BE4612-D961-4B39-BF5D-E089ADA2ACD8Q30392979-C470CA64-3A70-4E92-82F6-6FF4D940C479Q30392979-D923DD3B-8644-4D1F-BFB2-669AFBCC2A71Q30578967-A78A2830-0183-440A-9A63-2819FF8528E5Q33488336-3D5A682D-FD38-4361-B725-FBD7EA1A5600Q33488336-E03C6D36-4796-4B96-8D99-53316021336FQ33585588-7813FAEF-53EA-424B-8BD4-840CF3219548Q33585588-ED4875AF-0C4B-46E5-85A0-271F2C1E7D6BQ33610629-028473D5-BEFC-4821-9B29-3E321B7EA4FBQ33610629-70343EFD-67AA-4146-B232-78997FD8BBD7Q33610774-BEF7D82E-8715-4D63-BA0B-ACD6E7184300Q33616844-7EB917DC-A699-49A8-8652-8999EAB75A79Q33616844-A27B57F4-21BA-4699-8E6B-35411AF60BB3Q33628611-1C150FC1-A7AB-49D8-9898-84C6700B6E24Q33628611-6D73D6DD-5D68-4730-9835-95DF60A0338BQ33638894-9F4BFF52-1A16-473C-9732-1F923DC4E666Q33638894-D270C068-F08B-4EC9-99B5-DDCD58868BEDQ33649859-41ED3648-B7A0-48E1-A7BE-594DF465F495Q33649859-89DF28B5-A180-49B2-819D-C5A62F95E267Q33662676-1B75F26A-A0A4-427D-A64B-746592BAD186Q33662676-9F60B93C-36EB-446F-AE4C-A7CA552B1A5E
P2860
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Contributions of -Cell Dysfunc ...... e and Impaired Fasting Glucose
@nl
Contributions of beta-cell dys ...... and impaired fasting glucose.
@ast
Contributions of beta-cell dys ...... and impaired fasting glucose.
@en
type
label
Contributions of -Cell Dysfunc ...... e and Impaired Fasting Glucose
@nl
Contributions of beta-cell dys ...... and impaired fasting glucose.
@ast
Contributions of beta-cell dys ...... and impaired fasting glucose.
@en
altLabel
Contributions of -Cell Dysfunc ...... e and Impaired Fasting Glucose
@en
prefLabel
Contributions of -Cell Dysfunc ...... e and Impaired Fasting Glucose
@nl
Contributions of beta-cell dys ...... and impaired fasting glucose.
@ast
Contributions of beta-cell dys ...... and impaired fasting glucose.
@en
P2093
P921
P1433
P1476
Contributions of -Cell Dysfunc ...... e and Impaired Fasting Glucose
@en
Contributions of beta-cell dys ...... and impaired fasting glucose.
@en
P2093
Devjit Tripathy
M. A. Abdul-Ghani
Muhammad A Abdul-Ghani
P304
P356
10.2337/DC05-2179
10.2337/DIACARE.2951130
P407
P577
2006-05-01T00:00:00Z